Management of chronic hepatitis B: Consensus guidelines, Pulsus Group Inc
CANADIAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
The Canadian Association of Gastroenterology (CAG) Canadian Association for the Study of the Liver (CASL)

Note: (Optional)

Citation Builder

  •  
Return to Guidelines
 
Special Article December 2012, Volume 26 Issue 12: 917-938
 

Management of chronic hepatitis B: Consensus guidelines

CS Coffin | SK Fung | MM Ma

Chronic hepatitis B (CHB) is a dynamic disease that is influenced by host and virological factors. The management of CHB has become more complex with the increasing use of long-term oral nucleos/tide analogue antiviral therapies and the availability of novel diagnostic assays. Furthermore, there is often a lack of robust data to guide optimal management such as the selection of therapy, duration of treatment, potential antiviral side effects and the treatment of special populations. In November 2011, the Canadian Liver Foundation and the Canadian Association for the Study of the Liver convened a consensus conference to review the literature and analyze published data, including other international expert guidelines on CHB management. The proceedings of the consensus conference are summarized and provide updated clinical practice guidelines to assist Canadian health care providers in the prevention, diagnosis, assessment and treatment of CHB.

Antiviral therapy | Canadian | Chronic hepatitis B | Hepatitis B virus infection | Management
   Français   
          
Click to download PDF Reader
 
 




Copyright © Pulsus Group Inc.